Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Are omega-3 fatty acids ineffective for preventing atrial fibrillation recurrence?

Guo X, Dong J, Du X, Ma C.

J Am Coll Cardiol. 2013 Apr 9;61(14):1552. doi: 10.1016/j.jacc.2013.01.032. No abstract available.

2.

Omega-3 fatty acids and prevention of atrial fibrillation.

Song ZZ.

J Am Coll Cardiol. 2013 Jul 2;62(1):84. doi: 10.1016/j.jacc.2013.02.067. Epub 2013 Apr 3. No abstract available.

3.

Reply: To PMID 23265344.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC.

J Am Coll Cardiol. 2013 Jul 2;62(1):84-5. doi: 10.1016/j.jacc.2013.03.024. Epub 2013 Apr 3. No abstract available.

4.

Reply: To PMID 23265344.

Macchia A, Nul D, Grancelli H, Varini S, Mariani J, Doval HC.

J Am Coll Cardiol. 2013 Apr 9;61(14):1552-3. doi: 10.1016/j.jacc.2013.01.033. No abstract available.

5.

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC; GESICA Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):463-8. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19.

6.

N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.

Ozaydın M, Erdoğan D, Tayyar S, Uysal BA, Doğan A, Içli A, Ozkan E, Varol E, Türker Y, Arslan A.

Anadolu Kardiyol Derg. 2011 Jun;11(4):305-9. doi: 10.5152/akd.2011.080. Epub 2011 May 5.

7.

Failure of omega-3 fatty acids in atrial fibrillation? No deficiency of highly unsaturated fatty acids in the absence of heart failure.

Rupp H, Rupp TP, Alter P, Maisch B.

Europace. 2011 Sep;13(9):1357; author reply 1357-8. doi: 10.1093/europace/eur149. Epub 2011 May 11. No abstract available.

PMID:
21561901
8.

n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.

Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.

Europace. 2011 Feb;13(2):174-81. doi: 10.1093/europace/euq386. Epub 2010 Nov 8.

PMID:
21059740
9.

A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation.

Boos C, Ritzema J, More RS.

Heart. 2004 Sep;90(9):1063-4. No abstract available.

10.

Omega-3 fatty acids and cardiac arrhythmias.

Rix TA, Christensen JH, Schmidt EB.

Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):168-73. doi: 10.1097/MCO.0b013e32835bf39b. Review.

PMID:
23196815
11.

[Class-1C drugs for oral loading in the cardioversion of paroxysmal atrial fibrillation].

Capucci A, Rosi A, Villani GQ, Aschieri D, Piepoli M.

G Ital Cardiol. 1998 Dec;28(12):1422-30. Review. Italian. No abstract available.

PMID:
9887399
12.

Cardioversion of atrial fibrillation with ibutilide in an orthotopic heart transplant patient.

Kaufman LJ, Kofalvi AE, Hong RA, Moreno-Cabral CE, Low LL.

J Heart Lung Transplant. 1999 Oct;18(10):1018-20. Review. No abstract available.

PMID:
10561113
13.

[Atrial remodeling and anti-remodeling therapy in atrial fibrillation].

Neumann T, Hölschermann H.

Dtsch Med Wochenschr. 2006 Apr 21;131(16):884-7. German. No abstract available.

PMID:
16625482
14.

Electrical and pharmacologic cardioversion for atrial fibrillation.

Kim SS, Knight BP.

Med Clin North Am. 2008 Jan;92(1):101-20, xi. Review.

PMID:
18061000
15.

Using omega-3 fatty acids to treat persistent atrial fibrillation: time to fish or cut bait?

Sullivan RM, Olshansky B.

Heart Rhythm. 2012 Apr;9(4):492-3. doi: 10.1016/j.hrthm.2011.12.003. Epub 2011 Dec 6. No abstract available.

PMID:
22155322
16.

Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.

Demir K, Can I, Koc F, Vatankulu MA, Ayhan S, Akilli H, Aribas A, Alihanoglu Y, Altunkeser BB.

Med Princ Pract. 2011;20(5):464-9. doi: 10.1159/000327674. Epub 2011 Jul 11.

17.

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.

Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L.

Circulation. 2011 Sep 6;124(10):1100-6. doi: 10.1161/CIRCULATIONAHA.111.022194. Epub 2011 Aug 15.

18.

Electrical and pharmacologic cardioversion for atrial fibrillation.

Kim SS, Knight BP.

Cardiol Clin. 2009 Feb;27(1):95-107, ix. doi: 10.1016/j.ccl.2008.09.008. Review.

PMID:
19111767
19.

[Is cardioversion always needed in atrial fibrillation?].

Toivonen L.

Duodecim. 2003;119(3):171-2. Finnish. No abstract available.

PMID:
12650014
20.

Ablation of right and left atrial premature beats following cardioversion in patients with chronic atrial fibrillation refractory to antiarrhythmic drugs.

Natale A, Pisanó E, Beheiry S, Richey M, Leonelli F, Fanelli R, Potenza M, Tomassoni G.

Am J Cardiol. 2000 Jun 1;85(11):1372-5. No abstract available.

PMID:
10831959

Supplemental Content

Support Center